As of 2025-10-31, the Intrinsic Value of Frequency Therapeutics Inc (FREQ) is -10.52 USD. This FREQ valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.30 USD, the upside of Frequency Therapeutics Inc is -3,612.98%.
Based on its market price of 0.30 USD and our intrinsic valuation, Frequency Therapeutics Inc (FREQ) is overvalued by 3,612.98%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.52 - -10.52 | -10.52 | -3,612.98% |
| P/E | (34.44) - (37.13) | (37.05) | -12465.7% |
| DDM - Stable | (17.36) - (48.74) | (33.05) | -11131.9% |
| DDM - Multi | (16.57) - (36.47) | (22.82) | -7717.8% |
| Market Cap (mil) | 11.06 |
| Beta | 1.10 |
| Outstanding shares (mil) | 36.93 |
| Enterprise Value (mil) | -28.65 |
| Market risk premium | 5.00% |
| Cost of Equity | 10.19% |
| Cost of Debt | 5.00% |
| WACC | 7.27% |